Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

FIMRC Fundraiser x Parasites Without Borders Kicks Off This Spring

Throughout May, June, and July, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to Foundation for International Medical Relief of Children (FIMRC), for a total gift of up to $10,000. Founded in 2002 by Dr. Vikram D. Bakhru, FIMRC is a U.S.-based nonprofit organization that works to improve access to care through innovative, self-sustaining health programs. FIMRC works alongside communities to improve health from the ground up — including building necessary infrastructure, such as constructing or updating buildings; ensuring communities have access to a healthcare professional; and educating on preventive health.
Learn more at
fimrc.org

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

Covid-19 vaccine vial and syringe ready for injection

October 3, 2024

Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection | SARS-CoV-2-specific Plasma Cells are Not Durably Established in the Bone Marrow Long-lived Compartment after mRNA Vaccination | Effects of Losartan on Patients Hospitalized for Acute COVID-19 | Mechanisms of Long COVID and the Path Toward Therapeutics | Post-hospitalization COVID-19 Cognitive Deficits
COVID-19 patient lying in a hospital

September 26, 2024

Genetic Tracing of Market Wildlife and Viruses at the Epicenter of the COVID-19 Pandemic | Lower Mortality Risk Associated with Remdesivir + Dexamethasone versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19 | Changes in Memory and Cognition During the SARS-CoV-2 Human Challenge Study
Person with COVID laying in hospital bed while staff help with respiratory aid

September 19, 2024

Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023 | Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, 18 October 2023–9 March 2024
Doctors using microscopes to take a closer look at specimens

September 12, 2024

Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates | Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials | Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
COVID-19 vaccination

September 5, 2024

The Effect of Semaglutide on Mortality and COVID-19–Related Deaths: An Analysis From the SELECT Trial | Effectiveness of COVID-19 Vaccines to Prevent Long COVID: Data from Norway | Fibrin Drives Thromboinflammation and Neuropathology in COVID-19 | Post-Acute Sequelae of COVID (PASC or Long COVID): An Evidenced-based Approach
Miscroscope view of Covid Cells

August 30, 2024

Effectiveness of Historical Smallpox Vaccination against Mpox Clade II in Men in Denmark, France, the Netherlands and Spain, 2022 | Pemivibart is Less Active against Recent SARS-CoV-2 JN.1 Sublineages | U.S. Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 Patients | COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People | Post-acute COVID-19 Outcomes Including Participant-reported Long COVID: Amubarvimab/romlusevimab versus Placebo in the ACTIV-2 Trial

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

U.S. Centers for Disease Control and Prevention

Centers for Disease Control, US

International Society for Infectious Diseases

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Row triangle Shape Decorative svg added to bottom

Learn more about parasitic diseases and receive updates about Parasites Without Borders' initiatives and developments by subscribing to our newsletter.

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

Donate to Parasites Without Borders Today!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio